1. European healthcare policies for controlling drug expenditure;Ess;Pharmaco Economics,2003
2. National Agency for Medicines and Social Insurance Institution,2005
3. National Agency for Medicines and Social Insurance Institution,1999
4. Moilanen J, Knape N, Häkkinen U, et al. Health expenditure and financing 1995–2005. Implementing the OECD system of health accounts (SHA) in national statistical accounting. Final Report. STAKES, Reports 16/2008.
5. Pharmaceutical Pricing Policies in a Global Market. OECD Health Policy Studies,2008